MedTrace Logo

Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)

NCT00682890 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2014-08-20

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to determine if adding Metformin, a drug that reduces insulin resistance, to birth control pills will reduce the risk of developing type 2 diabetes, high blood pressure. high lipid levels and heart disease in women with PCOS

Conditions

  • Polycystic Ovary Syndrome
  • PCOS
  • Insulin Sensitivity

Interventions

DRUG

placebo

placebo birth control pill daily

DRUG

metformin

2000 mg per day for 3 months daily birth control pill

Sponsors & Collaborators

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Leo Dunn, MD · DSMB

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2009-12-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00682890 on ClinicalTrials.gov